NCT03262987 (USvsCTV) is a clinical trial in May-Thurner Syndrome, sponsored by Assiut University.

Who is sponsoring NCT03262987?

NCT03262987 is sponsored by Assiut University.

What condition does NCT03262987 study?

NCT03262987 studies May-Thurner Syndrome.

Is NCT03262987 still recruiting?

NCT03262987 is currently status unknown. Last updated 28 August 2017.

Last reviewed 2017-08-28 · How we verify

NCT03262987: USvsCTV

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Color Doppler U/S vs MSCT Venography in May-Thurner Syndrome

Status unknown Last updated 28 August 2017

What this trial tests

trial in May-Thurner Syndrome in 25 participants. Status unknown.

Timeline

1 October 2017

Primary endpoint
31 October 2018

30 December 2018

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	25
Start date	1 October 2017
Primary completion	31 October 2018
Estimated completion	30 December 2018

Conditions studied

May-Thurner Syndrome — all drugs for May-Thurner Syndrome →

Sponsor

Assiut University

Who can join

Adults 18 to 80, any sex, with May-Thurner Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

May-Thurner syndrome is the result of compression of the left common iliac vein between the right common iliac artery and overlying vertebrae. In This Study , We will detect the role of color doppler US in the diagnosis of May-Thurner Syndrome in comparison to Direct CT Venography

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for May-Thurner Syndrome

Currently open trials in the same condition.

NCT06888024 — Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI · NA · recruiting
NCT04067505 — Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study · Phase 3 · recruiting
NCT05628948 — Vascular Lab Resource (VLR) Biorepository · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03262987 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 28 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03262987.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing